[go: up one dir, main page]

MX2017002140A - Metodo de pegilacion. - Google Patents

Metodo de pegilacion.

Info

Publication number
MX2017002140A
MX2017002140A MX2017002140A MX2017002140A MX2017002140A MX 2017002140 A MX2017002140 A MX 2017002140A MX 2017002140 A MX2017002140 A MX 2017002140A MX 2017002140 A MX2017002140 A MX 2017002140A MX 2017002140 A MX2017002140 A MX 2017002140A
Authority
MX
Mexico
Prior art keywords
pegylation method
pegylation
pegylating
relates
present
Prior art date
Application number
MX2017002140A
Other languages
English (en)
Other versions
MX387205B (es
Inventor
S Gronke Robert
Jaquez Orlando
Original Assignee
Biogen Ma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biogen Ma Inc filed Critical Biogen Ma Inc
Publication of MX2017002140A publication Critical patent/MX2017002140A/es
Publication of MX387205B publication Critical patent/MX387205B/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A61K47/60Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52Cytokines; Lymphokines; Interferons
    • C07K14/555Interferons [IFN]
    • C07K14/565IFN-beta

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

La presente invención se relaciona a un método para pegilar interferon beta.
MX2017002140A 2014-08-19 2015-08-18 Método de pegilación. MX387205B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201461997000P 2014-08-19 2014-08-19
PCT/US2015/045678 WO2017030563A1 (en) 2014-08-19 2015-08-18 Pegylation method

Publications (2)

Publication Number Publication Date
MX2017002140A true MX2017002140A (es) 2017-08-21
MX387205B MX387205B (es) 2025-03-18

Family

ID=59559468

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2017002140A MX387205B (es) 2014-08-19 2015-08-18 Método de pegilación.

Country Status (13)

Country Link
US (1) US11318207B2 (es)
EP (2) EP3183264B1 (es)
CO (1) CO2017002512A2 (es)
CY (1) CY1123685T1 (es)
DK (1) DK3183264T3 (es)
ES (1) ES2824028T3 (es)
HR (1) HRP20201725T1 (es)
LT (1) LT3183264T (es)
MX (1) MX387205B (es)
RS (1) RS61128B1 (es)
SI (1) SI3183264T1 (es)
SM (1) SMT202100016T1 (es)
WO (1) WO2017030563A1 (es)

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3710795A (en) 1970-09-29 1973-01-16 Alza Corp Drug-delivery device with stretched, rate-controlling membrane
EP0082481B2 (en) 1981-12-23 1990-09-12 Schering Corporation Stabilised alpha-interferon formulations and their preparation
US4766106A (en) 1985-06-26 1988-08-23 Cetus Corporation Solubilization of proteins for pharmaceutical compositions using polymer conjugation
US4917888A (en) 1985-06-26 1990-04-17 Cetus Corporation Solubilization of immunotoxins for pharmaceutical compositions using polymer conjugation
JP2514950B2 (ja) 1986-03-10 1996-07-10 エフ・ホフマン―ラ ロシユ アーゲー 化学修飾蛋白質,その製造法および中間体
US5595732A (en) 1991-03-25 1997-01-21 Hoffmann-La Roche Inc. Polyethylene-protein conjugates
US5262564A (en) 1992-10-30 1993-11-16 Octamer, Inc. Sulfinic acid adducts of organo nitroso compounds useful as retroviral inactivating agents anti-retroviral agents and anti-tumor agents
DE69430251T2 (de) 1993-11-10 2002-11-07 Enzon, Inc. Verbesserte interferon-polymerkonjugate
DE69920002T2 (de) 1998-04-28 2005-09-22 Applied Research Systems Ars Holding N.V. Konjugate aus polyole und beta-interferon
TWI266801B (en) 1999-07-26 2006-11-21 Applied Research Systems Polyol-IFN-beta conjugates
JP2005526151A (ja) * 2002-01-18 2005-09-02 バイオゲン アイデック エムエー インク. 生物学的に活性な化合物の結合のための部分を有するポリアルキレングリコール
ATE361761T1 (de) * 2002-09-27 2007-06-15 Hoffmann La Roche Poly(ethylen glykol)-konjugate von insulinähnlichem wachstumfaktor bindenden protein-4
US20040180054A1 (en) 2003-03-13 2004-09-16 Hanmi Pharm. Co., Ltd. Physiologically active polypeptide conjugate having prolonged in vivo half-life
CU23556A1 (es) 2005-11-30 2010-07-20 Ct Ingenieria Genetica Biotech Estructura polimérica semejante a dendrímero para la obtención de conjugados de interés farmacéutico
GB0908393D0 (en) 2009-05-15 2009-06-24 Almac Sciences Scotland Ltd Labelling method
WO2011075391A1 (en) * 2009-12-15 2011-06-23 Schering Corporation Formulations of acadesine
AR080993A1 (es) 2010-04-02 2012-05-30 Hanmi Holdings Co Ltd Formulacion de accion prolongada de interferon beta donde se usa un fragmento de inmunoglobulina
CN102453089B (zh) 2010-10-25 2014-06-04 北京凯因科技股份有限公司 重组集成干扰素变异体聚乙二醇偶联物的制备和应用
WO2014130811A1 (en) 2013-02-22 2014-08-28 Biogen Idec Ma Inc Interferon beta formulation
CN103113466B (zh) 2013-03-01 2015-06-03 中国科学院过程工程研究所 聚乙二醇修饰的重组人干扰素β-1b及制备方法
CN103936847B (zh) 2013-12-24 2014-12-10 北京凯因科技股份有限公司 Peg-sa及其药物组合物

Also Published As

Publication number Publication date
SMT202100016T1 (it) 2021-03-15
CY1123685T1 (el) 2022-03-24
EP3183264B1 (en) 2020-07-29
ES2824028T3 (es) 2021-05-11
RS61128B1 (sr) 2020-12-31
US20170232111A1 (en) 2017-08-17
BR112017003162A2 (pt) 2017-11-28
WO2017030563A1 (en) 2017-02-23
EP3782652A1 (en) 2021-02-24
SI3183264T1 (sl) 2021-03-31
CO2017002512A2 (es) 2017-05-31
DK3183264T3 (da) 2020-11-02
EP3183264A1 (en) 2017-06-28
US11318207B2 (en) 2022-05-03
LT3183264T (lt) 2021-01-11
WO2017030563A8 (en) 2017-03-16
HRP20201725T1 (hr) 2021-03-05
MX387205B (es) 2025-03-18

Similar Documents

Publication Publication Date Title
GB2540015B (en) Intermediate linear positioning
IL251822A0 (en) Variants of interferon alpha-2B
PL3072835T3 (pl) Sposób transportu
EP3249070A4 (en) Rail
EP3249069A4 (en) Rail
IL257317B (en) Diamond compositions produced on the basis of lithography
EP3302205A4 (en) WASHER MACHINE
EP3356600A4 (en) PNEUMATIC BALLAST BLOWER FOR RAILWAY APPLICATIONS
GB201520055D0 (en) Saw
GB201420600D0 (en) The saw
MX2021012843A (es) Metodo de pegilacion.
IL256199A (en) A preparation containing a combination of peptides
MX2017002140A (es) Metodo de pegilacion.
GB201421458D0 (en) Saw
AU5512P (en) Happe Epichloe siegelii
GB201520425D0 (en) Saw
GB201520428D0 (en) Saw
GB201520423D0 (en) Saw
GB201520424D0 (en) Saw
GB201520422D0 (en) Saw
GB201519661D0 (en) Saw
GB201519538D0 (en) Saw
ZA201602749B (en) Dust collector
AU366282S (en) Saw
AU366280S (en) Saw